Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea flag South Korea · Delayed Price · Currency is KRW
54,900
+1,600 (3.00%)
At close: Aug 13, 2025, 3:30 PM KST

Next Biomedical Revenue

Next Biomedical had revenue of 3.77B KRW in the quarter ending March 31, 2025, with 165.94% growth. This brings the company's revenue in the last twelve months to 10.95B, up 124.19% year-over-year. In the year 2024, Next Biomedical had annual revenue of 9.54B with 95.46% growth.

Revenue (ttm)
10.95B
Revenue Growth
+124.19%
P/S Ratio
40.76
Revenue / Employee
n/a
Employees
n/a
Market Cap
446.17B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20249.54B4.66B95.46%
Dec 31, 20234.88B2.09B74.67%
Dec 31, 20222.80B527.74M23.28%
Dec 31, 20212.27B6.63M0.29%
Dec 31, 20202.26B1.46B182.32%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 308.59T
SK hynix 77.21T
LG Energy Solution 25.76T
Samsung Biologics 4,898.69B
Hyundai Motor Company 178.98T
Hanwha Aerospace 15.28T
Doosan Enerbility 15.88T
KB Financial Group 15.69T
Revenue Rankings